F. R. Appelbaum

1.5k total citations
25 papers, 1.1k citations indexed

About

F. R. Appelbaum is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, F. R. Appelbaum has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 7 papers in Oncology and 5 papers in Genetics. Recurrent topics in F. R. Appelbaum's work include Hematopoietic Stem Cell Transplantation (12 papers), Acute Myeloid Leukemia Research (7 papers) and Acute Lymphoblastic Leukemia research (4 papers). F. R. Appelbaum is often cited by papers focused on Hematopoietic Stem Cell Transplantation (12 papers), Acute Myeloid Leukemia Research (7 papers) and Acute Lymphoblastic Leukemia research (4 papers). F. R. Appelbaum collaborates with scholars based in United States, South Africa and Italy. F. R. Appelbaum's co-authors include Jack W. Singer, Paul J. Martin, Irwin D. Bernstein, Oliver W. Press, W. B. Nelp, Dana C. Matthews, Janet F. Eary, S. Glenn, D.R Fisher and Ted Gooley and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Blood.

In The Last Decade

F. R. Appelbaum

25 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. R. Appelbaum United States 14 552 310 287 273 245 25 1.1k
Daniel Espinouse France 19 410 0.7× 66 0.2× 590 2.1× 584 2.1× 87 0.4× 43 1.3k
Paola Masolini Italy 17 389 0.7× 78 0.3× 294 1.0× 110 0.4× 102 0.4× 24 849
M Weil France 16 374 0.7× 47 0.2× 446 1.6× 222 0.8× 377 1.5× 69 1.1k
Wichai Chinratanalab United States 11 413 0.7× 279 0.9× 512 1.8× 44 0.2× 96 0.4× 48 1.0k
Henderson Es United States 15 293 0.5× 48 0.2× 227 0.8× 153 0.6× 195 0.8× 29 693
Susan McKenzie United States 14 766 1.4× 42 0.1× 342 1.2× 158 0.6× 439 1.8× 19 1.2k
Emma Das‐Gupta United Kingdom 18 725 1.3× 42 0.1× 261 0.9× 212 0.8× 290 1.2× 34 1.2k
Mauricio Ocqueteau Chile 13 617 1.1× 48 0.2× 214 0.7× 101 0.4× 144 0.6× 33 933
J. L. Pico France 14 306 0.6× 62 0.2× 211 0.7× 47 0.2× 174 0.7× 23 894
SN Rabinowe United States 10 425 0.8× 66 0.2× 230 0.8× 348 1.3× 51 0.2× 16 804

Countries citing papers authored by F. R. Appelbaum

Since Specialization
Citations

This map shows the geographic impact of F. R. Appelbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. R. Appelbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. R. Appelbaum more than expected).

Fields of papers citing papers by F. R. Appelbaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. R. Appelbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. R. Appelbaum. The network helps show where F. R. Appelbaum may publish in the future.

Co-authorship network of co-authors of F. R. Appelbaum

This figure shows the co-authorship network connecting the top 25 collaborators of F. R. Appelbaum. A scholar is included among the top collaborators of F. R. Appelbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. R. Appelbaum. F. R. Appelbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Doney, K, Michael R. Loken, Eileen Bryant, Anajane G. Smith, & F. R. Appelbaum. (2008). Lack of utility of chimerism studies obtained 2–3 months after myeloablative hematopoietic cell transplantation for ALL. Bone Marrow Transplantation. 42(4). 271–274. 24 indexed citations
3.
4.
Deeg, H. Joachim, Jason Gotlib, C Beckham, et al.. (2002). Soluble TNF receptor fusion protein (etanercept) for the treatment of myelodysplastic syndrome. Leukemia. 16(2). 162–164. 2 indexed citations
5.
6.
Sullivan, Keith M., Claudio Anasetti, M. Horowitz, et al.. (1998). Unrelated and HLA‐Nonidentical Related Donor Marrow Transplantation forThalassemia and Leukemia: A Combined Report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant Registrya. Annals of the New York Academy of Sciences. 850(1). 312–324. 22 indexed citations
7.
8.
Slattery, John T., Jean E. Sanders, CD Buckner, et al.. (1995). Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics.. PubMed. 16(1). 31–42. 275 indexed citations
9.
Press, Oliver W., F. R. Appelbaum, Paul J. Martin, et al.. (1995). Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas. The Lancet. 346(8971). 336–340. 352 indexed citations
10.
Press, Oliver W., JF Eary, Peter J. Martin, et al.. (1994). PRELIMINARY RESULTS OF A PHASE II TRIAL OF IODINE-131-LABELED ANTI-CD20 (B1) ANTIBODY THERAPY WITH BONE MARROW RESCUE FOR PATIENTS WITH RELAPSED B CELL LYMPHOMAS. Journal of Immunotherapy. 16(2). 160–160. 8 indexed citations
11.
Boldt, David H., et al.. (1994). Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults. The Southwest Oncology Group experience.. PubMed. 8(12). 2118–26. 42 indexed citations
12.
Head, David R., et al.. (1994). Treatment outcome with chemotherapy in acute promyelocytic leukemia: the Southwest Oncology Group (SWOG) experience.. PubMed. 8 Suppl 2. S38–41. 13 indexed citations
13.
Langenmayer, Irmgard, Charles H. Weaver, C. Dean Buckner, et al.. (1994). Engraftment of patients with lymphoid malignancies transplanted with autologous bone marrow, peripheral blood stem cells or both. Open access LMU (Ludwid Maxmilian's Universitat Munchen). 1 indexed citations
14.
Flowers, Mary E.D., K Doney, R Storb, et al.. (1992). Marrow transplantation for Fanconi anemia with or without leukemic transformation: an update of the Seattle experience.. PubMed. 9(3). 167–73. 39 indexed citations
15.
Appelbaum, F. R.. (1990). Introduction and overview of interferon alfa in myeloproliferative and hemangiomatous diseases.. PubMed. 27(3 Suppl 4). 1–5. 7 indexed citations
16.
Hill, R.S., Patrizio Mazza, D. B. Amos, et al.. (1989). Engraftment in 86 patients with lymphoid malignancy after autologous marrow transplantation. Bone Marrow Transplantation. 4(1). 69–74. 35 indexed citations
17.
Appelbaum, F. R., et al.. (1989). Failure to immortalise human AML cells using human recombinant GMCSF in vitro and in vivo.. PubMed. 4 Suppl 3. 40–1. 3 indexed citations
18.
Bianco, JA, Brenda M. Sandmaier, C Badger, et al.. (1989). Specific marrow localization of an 131I-labeled anti-myeloid antibody in normal dogs: effects of a "cold" antibody pretreatment dose on marrow localization.. PubMed. 17(9). 929–34. 21 indexed citations
19.
Doney, K, Paul J. Martin, Rainer Storb, et al.. (1985). A randomized trial of antihuman thymocyte globulin versus murine monoclonal antihuman T-cell antibodies as immunosuppressive therapy for aplastic anemia.. PubMed. 13(6). 520–4. 30 indexed citations
20.
Cheever, Martin A., A Fefer, Philip D. Greenberg, et al.. (1982). Treatment of Hairy-Cell Leukemia with Chemoradiotherapy and Identical-Twin Bone-Marrow Transplantation. New England Journal of Medicine. 307(8). 479–481. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Espinouse Breakdown of academic impact, for papers by Paola Masolini Breakdown of academic impact, for papers by M Weil Breakdown of academic impact, for papers by Wichai Chinratanalab Breakdown of academic impact, for papers by Henderson Es Breakdown of academic impact, for papers by Susan McKenzie Breakdown of academic impact, for papers by Emma Das‐Gupta Breakdown of academic impact, for papers by Mauricio Ocqueteau Breakdown of academic impact, for papers by J. L. Pico Breakdown of academic impact, for papers by SN Rabinowe
Rankless by CCL
2026